Tirzepatide
Dual GIP and GLP-1 receptor agonist for diabetes and weight management
⭐⭐⭐⭐⭐Clinically Proven Results
Exceptional Weight Loss
Clinical programs consistently show 15–22% average weight reduction, leading the category.
Heart Health Benefits
Improves cardiometabolic markers while maintaining effective glycemic control.
FDA Approved*
Breakthrough therapy approved for diabetes and widely used in weight-management protocols.
Trizapatide
Tirzepatide
Dual GIP and GLP-1 receptor agonist for diabetes and weight management
⭐⭐⭐⭐⭐Clinically Proven Results
Exceptional Weight Loss
Clinical programs consistently show 15–22% average weight reduction, leading the category.
Heart Health Benefits
Improves cardiometabolic markers while maintaining effective glycemic control.
FDA Approved*
Breakthrough therapy approved for diabetes and widely used in weight-management protocols.
